Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Degree of MDM2 Amplification Affects Clinical Outcomes in Dedifferentiated Liposarcoma.

Bill KLJ, Seligson ND, Hays JL, Awasthi A, Demoret B, Stets CW, Duggan MC, Bupathi M, Brock GN, Millis SZ, Shakya R, Timmers CD, Wakely PE Jr, Pollock RE, Chen JL.

Oncologist. 2019 Jul;24(7):989-996. doi: 10.1634/theoncologist.2019-0047. Epub 2019 Apr 24.

2.

Lumen-apposing metal stent-assisted electrohydraulic lithotripsy and mechanical lithotripsy for cholelithiasis in a nonsurgical patient.

Nasser A, Bill K, Barawi M.

VideoGIE. 2019 Mar 4;4(4):159-160. doi: 10.1016/j.vgie.2018.12.016. eCollection 2019 Apr. No abstract available.

3.

miR-133a function in the pathogenesis of dedifferentiated liposarcoma.

Yu PY, Lopez G, Braggio D, Koller D, Bill KLJ, Prudner BC, Zewdu A, Chen JL, Iwenofu OH, Lev D, Strohecker AM, Fenger JM, Pollock RE, Guttridge DC.

Cancer Cell Int. 2018 Jun 26;18:89. doi: 10.1186/s12935-018-0583-2. eCollection 2018.

4.

The diagnosis and staging of pancreatic cancer: A comparison of endoscopic ultrasound and computed tomography with pancreas protocol.

Du T, Bill KA, Ford J, Barawi M, Hayward RD, Alame A, Berri RN.

Am J Surg. 2018 Mar;215(3):472-475. doi: 10.1016/j.amjsurg.2017.11.021. Epub 2017 Nov 21.

PMID:
29174773
5.

Exosome-Derived miR-25-3p and miR-92a-3p Stimulate Liposarcoma Progression.

Casadei L, Calore F, Creighton CJ, Guescini M, Batte K, Iwenofu OH, Zewdu A, Braggio DA, Bill KL, Fadda P, Lovat F, Lopez G, Gasparini P, Chen JL, Kladney RD, Leone G, Lev D, Croce CM, Pollock RE.

Cancer Res. 2017 Jul 15;77(14):3846-3856. doi: 10.1158/0008-5472.CAN-16-2984. Epub 2017 Jun 6.

6.

Liposarcoma: molecular targets and therapeutic implications.

Bill KL, Casadei L, Prudner BC, Iwenofu H, Strohecker AM, Pollock RE.

Cell Mol Life Sci. 2016 Oct;73(19):3711-8. doi: 10.1007/s00018-016-2266-2. Epub 2016 May 12. Review.

PMID:
27173057
7.

SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma.

Bill KL, Garnett J, Meaux I, Ma X, Creighton CJ, Bolshakov S, Barriere C, Debussche L, Lazar AJ, Prudner BC, Casadei L, Braggio D, Lopez G, Zewdu A, Bid H, Lev D, Pollock RE.

Clin Cancer Res. 2016 Mar 1;22(5):1150-60. doi: 10.1158/1078-0432.CCR-15-1522. Epub 2015 Oct 16.

8.

HDAC Inhibition for the Treatment of Epithelioid Sarcoma: Novel Cross Talk Between Epigenetic Components.

Lopez G, Song Y, Lam R, Ruder D, Creighton CJ, Bid HK, Bill KL, Bolshakov S, Zhang X, Lev D, Pollock RE.

Mol Cancer Res. 2016 Jan;14(1):35-43. doi: 10.1158/1541-7786.MCR-15-0295. Epub 2015 Sep 22.

9.

HDAC8, A Potential Therapeutic Target for the Treatment of Malignant Peripheral Nerve Sheath Tumors (MPNST).

Lopez G, Bill KL, Bid HK, Braggio D, Constantino D, Prudner B, Zewdu A, Batte K, Lev D, Pollock RE.

PLoS One. 2015 Jul 22;10(7):e0133302. doi: 10.1371/journal.pone.0133302. eCollection 2015.

10.

The hepatocyte growth factor receptor as a potential therapeutic target for dedifferentiated liposarcoma.

Bill KL, Garnett J, Ma X, May CD, Bolshakov S, Lazar AJ, Lev DC, Pollock RE.

Lab Invest. 2015 Aug;95(8):951-61. doi: 10.1038/labinvest.2015.62. Epub 2015 Jun 1.

11.

Heterogeneity and immunophenotypic plasticity of malignant cells in human liposarcomas.

Zhang Y, Young ED, Bill K, Belousov R, Peng T, Lazar AJ, Pollock RE, Simmons PJ, Lev D, Kolonin MG.

Stem Cell Res. 2013 Sep;11(2):772-81. doi: 10.1016/j.scr.2013.04.011. Epub 2013 May 12.

12.

Senescent remodeling of the immune system and its contribution to the predisposition of the elderly to infections.

Dewan SK, Zheng SB, Xia SJ, Bill K.

Chin Med J (Engl). 2012 Sep;125(18):3325-31. Review.

PMID:
22964331
13.

MiR-155 is a liposarcoma oncogene that targets casein kinase-1α and enhances β-catenin signaling.

Zhang P, Bill K, Liu J, Young E, Peng T, Bolshakov S, Hoffman A, Song Y, Demicco EG, Terrada DL, Creighton CJ, Anderson ML, Lazar AJ, Calin GG, Pollock RE, Lev D.

Cancer Res. 2012 Apr 1;72(7):1751-62. doi: 10.1158/0008-5472.CAN-11-3027. Epub 2012 Feb 20.

14.

High-resolution genomic mapping reveals consistent amplification of the fibroblast growth factor receptor substrate 2 gene in well-differentiated and dedifferentiated liposarcoma.

Wang X, Asmann YW, Erickson-Johnson MR, Oliveira JL, Zhang H, Moura RD, Lazar AJ, Lev D, Bill K, Lloyd RV, Yaszemski MJ, Maran A, Oliveira AM.

Genes Chromosomes Cancer. 2011 Nov;50(11):849-58. doi: 10.1002/gcc.20906. Epub 2011 Jul 26.

PMID:
21793095
15.

Activated MET is a molecular prognosticator and potential therapeutic target for malignant peripheral nerve sheath tumors.

Torres KE, Zhu QS, Bill K, Lopez G, Ghadimi MP, Xie X, Young ED, Liu J, Nguyen T, Bolshakov S, Belousov R, Wang S, Lahat G, Liu J, Hernandez B, Lazar AJ, Lev D.

Clin Cancer Res. 2011 Jun 15;17(12):3943-55. doi: 10.1158/1078-0432.CCR-11-0193. Epub 2011 May 3.

16.

Vimentin is a novel AKT1 target mediating motility and invasion.

Zhu QS, Rosenblatt K, Huang KL, Lahat G, Brobey R, Bolshakov S, Nguyen T, Ding Z, Belousov R, Bill K, Luo X, Lazar A, Dicker A, Mills GB, Hung MC, Lev D.

Oncogene. 2011 Jan 27;30(4):457-70. doi: 10.1038/onc.2010.421. Epub 2010 Sep 20.

17.

Evaluation of alternative electron donors for denitrifying moving bed biofilm reactors (MBBRs).

Bill KA, Bott CB, Murthy SN.

Water Sci Technol. 2009;60(10):2647-57. doi: 10.2166/wst.2009.622.

PMID:
19923771
18.

Towards absolute quantification of therapeutic monoclonal antibody in serum by LC-MS/MS using isotope-labeled antibody standard and protein cleavage isotope dilution mass spectrometry.

Heudi O, Barteau S, Zimmer D, Schmidt J, Bill K, Lehmann N, Bauer C, Kretz O.

Anal Chem. 2008 Jun 1;80(11):4200-7. doi: 10.1021/ac800205s. Epub 2008 May 9.

PMID:
18465883
19.

Effect of constant and variable domain glycosylation on pharmacokinetics of therapeutic antibodies in mice.

Millward TA, Heitzmann M, Bill K, Längle U, Schumacher P, Forrer K.

Biologicals. 2008 Jan;36(1):41-7. Epub 2007 Sep 24.

PMID:
17890101
20.

Profound vasodilatory hypotension in a patient with known empty sella syndrome following cardiac surgery.

Lamont SN, McBride WT, Bill KM, Varadarajan B.

Anaesthesia. 2007 Aug;62(8):846-9.

21.

The importance of mouth care.

Bill K.

Nurs Stand. 2000 Apr 19-25;14(31):57.

PMID:
11973956
22.

Recombinant human complement C5a receptor antagonist reduces infarct size after surgical revascularization.

Riley RD, Sato H, Zhao ZQ, Thourani VH, Jordan JE, Fernandez AX, Ma XL, Hite DR, Rigel DF, Pellas TC, Peppard J, Bill KA, Lappe RW, Vinten-Johansen J.

J Thorac Cardiovasc Surg. 2000 Aug;120(2):350-8.

23.

Severe cardiovascular depression with remifentanil.

Elliott P, O'Hare R, Bill KM, Phillips AS, Gibson FM, Mirakhur RK.

Anesth Analg. 2000 Jul;91(1):58-61.

PMID:
10866887
24.

Novel C5a receptor antagonists regulate neutrophil functions in vitro and in vivo.

Pellas TC, Boyar W, van Oostrum J, Wasvary J, Fryer LR, Pastor G, Sills M, Braunwalder A, Yarwood DR, Kramer R, Kimble E, Hadala J, Haston W, Moreira-Ludewig R, Uziel-Fusi S, Peters P, Bill K, Wennogle LP.

J Immunol. 1998 Jun 1;160(11):5616-21.

25.

Effects of omeprazole, with and without metoclopramide, in elective obstetric anaesthesia.

Orr DA, Bill KM, Gillon KR, Wilson CM, Fogarty DJ, Moore J.

Anaesthesia. 1993 Feb;48(2):114-9.

26.

Psychomotor and clinical assessment of flumazenil as an antagonist of midazolam.

Bill KM, Fee JP, Clarke RS.

J R Soc Med. 1991 May;84(5):277-9.

27.

Effect of stimulation of the P6 antiemetic point on postoperative nausea and vomiting.

Dundee JW, Ghaly RG, Bill KM, Chestnutt WN, Fitzpatrick KT, Lynas AG.

Br J Anaesth. 1989 Nov;63(5):612-8.

28.

A comparison between propofol and thiopentone as induction agents in obstetric anaesthesia.

Moore J, Bill KM, Flynn RJ, McKeating KT, Howard PJ.

Anaesthesia. 1989 Sep;44(9):753-7.

29.

Resolution of cytochrome-c oxidase.

Azzi A, Broger C, Bill K, Corbley MJ.

Methods Enzymol. 1986;126:72-7. No abstract available.

PMID:
2856141
30.

Affinity chromatography purification of cytochrome-c oxidase from bovine heart mitochondria and other sources.

Broger C, Bill K, Azzi A.

Methods Enzymol. 1986;126:64-72. No abstract available.

PMID:
2856140
31.

Interaction of reduced and oxidized cytochrome c with the mitochondrial cytochrome c oxidase and bc1-complex.

Bill K, Azzi A.

Biochem Biophys Res Commun. 1984 Apr 16;120(1):124-30.

PMID:
6324789
32.

Adenomyoma (pancreatic heterotopia) of the duodenum producing common bile duct obstruction.

Bill K, Belber JP, Carson JW.

Gastrointest Endosc. 1982 Aug;28(3):182-4. No abstract available.

PMID:
7129042
33.

An active cytochrome c oxidase depleted of subunit III prepared by covalent chromatography on yeast cytochrome c.

Bill K, Azzi A.

Biochem Biophys Res Commun. 1982 Jun 30;106(4):1203-9. No abstract available.

PMID:
6288042
34.

Affinity chromatography purification of cytochrome c binding enzymes.

Azzi A, Bill K, Broger C.

Proc Natl Acad Sci U S A. 1982 Apr;79(8):2447-50.

36.

Human milk banking. Effect of refrigeration on cellular components.

Pittard WB 3rd, Bill K.

Clin Pediatr (Phila). 1981 Jan;20(1):31-3.

PMID:
7449243
37.

Affinity chromatography purification of cytochrome c oxidase: use of a yeast cytochrome c - thiol-Sepharose 4B column.

Bill K, Casey RP, Broger C, Azzi A.

FEBS Lett. 1980 Nov 3;120(2):248-50. No abstract available.

38.

Immunoglobulin synthesis by cord blood lymphocytes.

Pittard WB 3rd, Bill K, Epstein DM, Polmar SH.

Experientia. 1979 Oct 15;35(10):1321-2.

PMID:
499408
39.

Differentiation of cord blood lymphocytes into IgA-producing cells in response to breast milk stimulatory factor.

Pittard WB 3rd, Bill K.

Clin Immunol Immunopathol. 1979 Aug;13(4):430-4. No abstract available.

PMID:
314877
40.

Excretion of technetium in human milk.

Pittard WB 3rd, Bill K, Fletcher BD.

J Pediatr. 1979 Apr;94(4):605-7. No abstract available.

PMID:
430299
41.

Immunoregulation by breast milk cells.

Pittard WB 3rd, Bill K.

Cell Immunol. 1979 Feb;42(2):437-41. No abstract available.

PMID:
427883
42.

Diverticulum of the gallbladder presenting as an intraluminal radiolucency.

Belber JP, Gutierrez A, Bill K.

Gastrointest Endosc. 1978 May;24(4):180-1. No abstract available.

PMID:
417963
43.
44.

Supplemental Content

Support Center